Back to Journals » Journal of Hepatocellular Carcinoma » Volume 11

Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma

Total article views   HTML views PDF downloads Totals
927 Dovepress* 878+ 20 898
PubMed Central* 49 21 70
Totals 927 41 968
*Since 4 March 2024
Total mentioned Facebook Delicious Reddit Twitter Others
10 0 0 0 5 5

View citations on PubMed Central and Google Scholar